Ami Fadia
Stock Analyst at Needham
(4.61)
# 208
Out of 5,090 analysts
405
Total ratings
54.62%
Success rate
27.54%
Average return
Main Sectors:
Stocks Rated by Ami Fadia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRAX Praxis Precision Medicines | Reiterates: Buy | $250 | $191.83 | +30.32% | 14 | Dec 1, 2025 | |
| HRMY Harmony Biosciences Holdings | Reiterates: Buy | $42 | $38.25 | +9.80% | 39 | Nov 24, 2025 | |
| DAWN Day One Biopharmaceuticals | Reiterates: Buy | $16 | $8.41 | +90.25% | 22 | Nov 24, 2025 | |
| RVMD Revolution Medicines | Maintains: Buy | $66 → $72 | $78.51 | -8.29% | 27 | Nov 6, 2025 | |
| ACAD ACADIA Pharmaceuticals | Maintains: Buy | $28 → $29 | $26.59 | +9.08% | 12 | Nov 6, 2025 | |
| AXSM Axsome Therapeutics | Reiterates: Buy | $154 | $148.41 | +3.77% | 17 | Nov 4, 2025 | |
| NBIX Neurocrine Biosciences | Maintains: Buy | $170 → $184 | $153.75 | +19.67% | 16 | Oct 29, 2025 | |
| ALKS Alkermes | Maintains: Buy | $43 → $44 | $29.30 | +50.20% | 4 | Oct 29, 2025 | |
| NMRA Neumora Therapeutics | Maintains: Buy | $6 → $8 | $2.30 | +248.58% | 10 | Oct 28, 2025 | |
| AVDL Avadel Pharmaceuticals | Downgrades: Hold | n/a | $21.36 | - | 37 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $15.16 | +25.33% | 1 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $4.39 | +173.35% | 1 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $12.48 | +124.45% | 1 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $6.75 | +63.08% | 20 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $96 | $96.20 | -0.21% | 31 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $181.82 | - | 43 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $202 | $166.39 | +21.40% | 34 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $39.36 | - | 23 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $29.48 | +18.74% | 1 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $29 | $7.19 | +303.34% | 21 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $240 → $320 | $16.48 | +1,841.75% | 2 | Feb 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $63 → $75 | $23.97 | +212.89% | 7 | Jan 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $15 → $23 | $0.45 | +4,898.33% | 4 | Oct 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $64 → $63 | $13.49 | +367.01% | 5 | Sep 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $28.41 | - | 9 | Oct 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $22 | $1.30 | +1,592.31% | 4 | Jan 3, 2018 |
Praxis Precision Medicines
Dec 1, 2025
Reiterates: Buy
Price Target: $250
Current: $191.83
Upside: +30.32%
Harmony Biosciences Holdings
Nov 24, 2025
Reiterates: Buy
Price Target: $42
Current: $38.25
Upside: +9.80%
Day One Biopharmaceuticals
Nov 24, 2025
Reiterates: Buy
Price Target: $16
Current: $8.41
Upside: +90.25%
Revolution Medicines
Nov 6, 2025
Maintains: Buy
Price Target: $66 → $72
Current: $78.51
Upside: -8.29%
ACADIA Pharmaceuticals
Nov 6, 2025
Maintains: Buy
Price Target: $28 → $29
Current: $26.59
Upside: +9.08%
Axsome Therapeutics
Nov 4, 2025
Reiterates: Buy
Price Target: $154
Current: $148.41
Upside: +3.77%
Neurocrine Biosciences
Oct 29, 2025
Maintains: Buy
Price Target: $170 → $184
Current: $153.75
Upside: +19.67%
Alkermes
Oct 29, 2025
Maintains: Buy
Price Target: $43 → $44
Current: $29.30
Upside: +50.20%
Neumora Therapeutics
Oct 28, 2025
Maintains: Buy
Price Target: $6 → $8
Current: $2.30
Upside: +248.58%
Avadel Pharmaceuticals
Oct 22, 2025
Downgrades: Hold
Price Target: n/a
Current: $21.36
Upside: -
Oct 13, 2025
Initiates: Buy
Price Target: $19
Current: $15.16
Upside: +25.33%
Oct 13, 2025
Initiates: Buy
Price Target: $12
Current: $4.39
Upside: +173.35%
Oct 13, 2025
Initiates: Buy
Price Target: $28
Current: $12.48
Upside: +124.45%
Sep 30, 2025
Reiterates: Buy
Price Target: $11
Current: $6.75
Upside: +63.08%
Sep 29, 2025
Downgrades: Hold
Price Target: $96
Current: $96.20
Upside: -0.21%
Sep 24, 2025
Reiterates: Hold
Price Target: n/a
Current: $181.82
Upside: -
Aug 28, 2025
Reiterates: Buy
Price Target: $202
Current: $166.39
Upside: +21.40%
Jun 17, 2025
Reiterates: Hold
Price Target: n/a
Current: $39.36
Upside: -
May 28, 2025
Initiates: Buy
Price Target: $35
Current: $29.48
Upside: +18.74%
May 2, 2025
Reiterates: Buy
Price Target: $29
Current: $7.19
Upside: +303.34%
Feb 1, 2021
Maintains: Outperform
Price Target: $240 → $320
Current: $16.48
Upside: +1,841.75%
Jan 21, 2021
Downgrades: Market Perform
Price Target: $63 → $75
Current: $23.97
Upside: +212.89%
Oct 1, 2020
Maintains: Market Perform
Price Target: $15 → $23
Current: $0.45
Upside: +4,898.33%
Sep 17, 2020
Maintains: Outperform
Price Target: $64 → $63
Current: $13.49
Upside: +367.01%
Oct 1, 2018
Upgrades: Market Perform
Price Target: n/a
Current: $28.41
Upside: -
Jan 3, 2018
Initiates: Outperform
Price Target: $22
Current: $1.30
Upside: +1,592.31%